{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T05:02:49Z","timestamp":1791349369450,"version":"4.3.1"},"reference-count":326,"publisher":"Oxford University Press (OUP)","issue":"34","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Heart J"],"published-print":{"date-parts":[[2015,9,7]]},"DOI":"10.1093\/eurheartj\/ehv239","type":"journal-article","created":{"date-parts":[[2015,6,11]],"date-time":"2015-06-11T07:21:52Z","timestamp":1434007312000},"page":"2288-2296","source":"Crossref","is-referenced-by-count":232,"title":["Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes"],"prefix":"10.1093","volume":"36","author":[{"given":"Ele","family":"Ferrannini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,6,10]]},"reference":[{"key":"2015090700384559000_36.34.2288.1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-9028"},{"key":"2015090700384559000_36.34.2288.2","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.667"},{"key":"2015090700384559000_36.34.2288.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2010.11.005"},{"key":"2015090700384559000_36.34.2288.4","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0246"},{"key":"2015090700384559000_36.34.2288.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.04.009"},{"key":"2015090700384559000_36.34.2288.6","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes."},{"key":"2015090700384559000_36.34.2288.7","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1263-9"},{"key":"2015090700384559000_36.34.2288.8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa012512"},{"key":"2015090700384559000_36.34.2288.9","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-1133"},{"key":"2015090700384559000_36.34.2288.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292703"},{"key":"2015090700384559000_36.34.2288.11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI114142"},{"key":"2015090700384559000_36.34.2288.12","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.10.2461"},{"key":"2015090700384559000_36.34.2288.13","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.6.1640"},{"key":"2015090700384559000_36.34.2288.14","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030723"},{"key":"2015090700384559000_36.34.2288.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1896-4"},{"key":"2015090700384559000_36.34.2288.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-002-0878-6"},{"key":"2015090700384559000_36.34.2288.17","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1195-5"},{"key":"2015090700384559000_36.34.2288.18","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0465"},{"key":"2015090700384559000_36.34.2288.19","doi-asserted-by":"publisher","DOI":"10.2337\/diab.36.3.274"},{"key":"2015090700384559000_36.34.2288.20","doi-asserted-by":"publisher","DOI":"10.1053\/meta.2002.34700"},{"key":"2015090700384559000_36.34.2288.21","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0387"},{"key":"2015090700384559000_36.34.2288.22","doi-asserted-by":"crossref","unstructured":"Blazquez E Velazquez E Hurtado-Carneiro V Ruiz-Albusac JM . Insulin in the brain: its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol 2014;5:161.","DOI":"10.3389\/fendo.2014.00161"},{"key":"2015090700384559000_36.34.2288.23","doi-asserted-by":"publisher","DOI":"10.1001\/jama.281.21.2005"},{"key":"2015090700384559000_36.34.2288.24","doi-asserted-by":"publisher","DOI":"10.2337\/diab.44.11.1249"},{"key":"2015090700384559000_36.34.2288.25","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07019-6"},{"key":"2015090700384559000_36.34.2288.26","doi-asserted-by":"publisher","DOI":"10.1007\/s13668-014-0099-x"},{"key":"2015090700384559000_36.34.2288.27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"2015090700384559000_36.34.2288.28","doi-asserted-by":"publisher","DOI":"10.1007\/PL00002934"},{"key":"2015090700384559000_36.34.2288.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807233390404"},{"key":"2015090700384559000_36.34.2288.30","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-1013"},{"key":"2015090700384559000_36.34.2288.31","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70219-0"},{"key":"2015090700384559000_36.34.2288.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"2015090700384559000_36.34.2288.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1008862"},{"key":"2015090700384559000_36.34.2288.34","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)12131-1"},{"key":"2015090700384559000_36.34.2288.35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.3.397"},{"key":"2015090700384559000_36.34.2288.36","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.10.1845"},{"key":"2015090700384559000_36.34.2288.37","doi-asserted-by":"publisher","DOI":"10.1007\/s001250051249"},{"key":"2015090700384559000_36.34.2288.38","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehl363"},{"key":"2015090700384559000_36.34.2288.39","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68967-8"},{"key":"2015090700384559000_36.34.2288.40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198708063170605"},{"key":"2015090700384559000_36.34.2288.41","doi-asserted-by":"publisher","DOI":"10.1007\/BF00403180"},{"key":"2015090700384559000_36.34.2288.42","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1684-1"},{"key":"2015090700384559000_36.34.2288.43","doi-asserted-by":"publisher","DOI":"10.1007\/BF02743273"},{"key":"2015090700384559000_36.34.2288.44","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1990.03440210043030"},{"key":"2015090700384559000_36.34.2288.45","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.683"},{"key":"2015090700384559000_36.34.2288.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.03.005"},{"key":"2015090700384559000_36.34.2288.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.07.012"},{"key":"2015090700384559000_36.34.2288.48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.548206"},{"key":"2015090700384559000_36.34.2288.49","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1177"},{"key":"2015090700384559000_36.34.2288.50","doi-asserted-by":"publisher","DOI":"10.1007\/s001250050581"},{"key":"2015090700384559000_36.34.2288.51","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.13.3.367"},{"key":"2015090700384559000_36.34.2288.52","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0919"},{"key":"2015090700384559000_36.34.2288.53","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.7.1135"},{"key":"2015090700384559000_36.34.2288.54","doi-asserted-by":"crossref","unstructured":"Howard G O'Leary DH Zaccaro D Haffner S Rewers M Hamman R Selby JV Saad MF Savage P Bergman R . Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809\u20131817.","DOI":"10.1161\/01.CIR.93.10.1809"},{"key":"2015090700384559000_36.34.2288.55","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2000.00280.x"},{"key":"2015090700384559000_36.34.2288.56","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-0334"},{"key":"2015090700384559000_36.34.2288.57","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.10.3069"},{"key":"2015090700384559000_36.34.2288.58","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1654"},{"key":"2015090700384559000_36.34.2288.59","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(83)90169-8"},{"key":"2015090700384559000_36.34.2288.60","doi-asserted-by":"publisher","DOI":"10.1007\/BF00395550"},{"key":"2015090700384559000_36.34.2288.61","unstructured":"Eschwege E Richard JL Thibult N Ducimetiere P Warnet JM Claude JR Rosselin GE . Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Hor Metabolic Res Supplement Series 1985;15:41\u201346."},{"key":"2015090700384559000_36.34.2288.62","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.2.2.154"},{"key":"2015090700384559000_36.34.2288.63","doi-asserted-by":"publisher","DOI":"10.1007\/BF00275270"},{"key":"2015090700384559000_36.34.2288.64","doi-asserted-by":"crossref","unstructured":"Fuller JH Shipley MJ Rose G Jarrett RJ Keen H . Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study. Lancet 1980;1:1373\u20131376.","DOI":"10.1016\/S0140-6736(80)92651-3"},{"key":"2015090700384559000_36.34.2288.65","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.6.2.123"},{"key":"2015090700384559000_36.34.2288.66","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.2.2.131"},{"key":"2015090700384559000_36.34.2288.67","unstructured":"Pyorala K Uusitupa M Laakso M Siitonen O Niskanen L Ronnemaa T . Macrovascular complications in relation to hyperinsulinaemia in non-insulin-dependent diabetes mellitus. Diabete Metab 1987;13:345\u2013349."},{"key":"2015090700384559000_36.34.2288.68","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.12381"},{"key":"2015090700384559000_36.34.2288.69","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.12.1333"},{"key":"2015090700384559000_36.34.2288.70","doi-asserted-by":"crossref","unstructured":"Shore AC Colhoun HM Natali A Palombo C \u00d6stling G Aizawa K Kennb\u00e4ck C Casanova F Persson M Gooding K Gates PE Kahn F Looker HC Adams F Belch J Pinnoli S Venturi E Morizzo C Goncalves I Ladenvall C Nilsson J ; SUMMIT consortium. Measures of atherosclerotic burden are associated with clinically manifest cardiovascular disease in type 2 diabetes: a European cross-sectional study. J Intern Med 2015 Mar 9. doi:10.1111\/joim.12359 doi:10.1111\/joim.12359. [Epub ahead of print]","DOI":"10.1111\/joim.12359"},{"key":"2015090700384559000_36.34.2288.71","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.112.300948"},{"key":"2015090700384559000_36.34.2288.72","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2558"},{"key":"2015090700384559000_36.34.2288.73","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1203858"},{"key":"2015090700384559000_36.34.2288.74","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2129"},{"key":"2015090700384559000_36.34.2288.75","doi-asserted-by":"crossref","unstructured":"Lozano R Naghavi M Foreman K Lim S Shibuya K Aboyans V, V Abraham J Adair T Aggarwal R Ahn SY Alvarado M Anderson HR Anderson LM Andrews KG Atkinson C Baddour LM Barker-Collo S Bartels DH Bell ML Benjamin EJ Bennett D Bhalla K Bikbov B Bin Abdulhak A Birbeck G Blyth F Bolliger I Boufous S Bucello C Burch M Burney P Carapetis J Chen H Chou D Chugh SS Coffeng LE Colan SD Colquhoun S Colson KE Condon J Connor MD Cooper LT Corriere M Cortinovis M de Vaccaro KC Couser W Cowie BC Criqui MH Cross M Dabhadkar KC Dahodwala N De Leo D Degenhardt L Delossantos A Denenberg J Des Jarlais DC Dharmaratne SD Dorsey ER Driscoll T Duber H Ebel B Erwin PJ Espindola P Ezzati M Feigin V Flaxman AD Forouzanfar MH Fowkes FG Franklin R Fransen M Freeman MK Gabriel SE Gakidou E Gaspari F Gillum RF Gonzalez-Medina D Halasa YA Haring D Harrison JE Havmoeller R Hay RJ Hoen B Hotez PJ Hoy D Jacobsen KH James SL Jasrasaria R Jayaraman S Johns N Karthikeyan G Kassebaum N Keren A Khoo JP Knowlton LM Kobusingye O Koranteng A Krishnamurthi R Lipnick M Lipshultz SE Ohno SL Mabweijano J MacIntyre MF Mallinger L March L Marks GB Marks R Matsumori A Matzopoulos R Mayosi BM McAnulty JH McDermott MM McGrath J Mensah GA Merriman TR Michaud C Miller M Miller TR Mock C Mocumbi AO Mokdad AA Moran A Mulholland K Nair MN Naldi L Narayan KM Nasseri K Norman P O'Donnell M Omer SB Ortblad K Osborne R Ozgediz D Pahari B Pandian JD Rivero AP Padilla RP Perez-Ruiz F Perico N Phillips D Pierce K Pope CA 3rd Porrini E Pourmalek F Raju M Ranganathan D Rehm JT Rein DB Remuzzi G Rivara FP Roberts T De Le\u00f3n FR Rosenfeld LC Rushton L Sacco RL Salomon JA Sampson U Sanman E Schwebel DC Segui-Gomez M Shepard DS Singh D Singleton J Sliwa K Smith E Steer A Taylor JA Thomas B Tleyjeh IM Towbin JA Truelsen T Undurraga EA Venketasubramanian N Vijayakumar L Vos T Wagner GR Wang M Wang W Watt K Weinstock MA Weintraub R Wilkinson JD Woolf AD Wulf S Yeh PH Yip P Zabetian A Zheng ZJ Lopez AD Murray CJ AlMazroa MA Memish ZA . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380:2095\u20132128.","DOI":"10.1016\/S0140-6736(12)61728-0"},{"key":"2015090700384559000_36.34.2288.76","unstructured":"WHO Global Health Estimates Summary Tables: Deaths by Cause, Age and Sex, 2000\u20132011. Geneva, World Health Organization. 2012. http:\/\/www.who.int\/healthinfo\/global_burden_disease\/estimates_regional\/en\/ (24 February 2015)."},{"key":"2015090700384559000_36.34.2288.77","doi-asserted-by":"crossref","unstructured":"The Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration. Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment. Lancet Diabetes Endocrinol 2014;2:633\u2013647.","DOI":"10.1016\/S2213-8587(14)70102-0"},{"key":"2015090700384559000_36.34.2288.78","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)17018-9"},{"key":"2015090700384559000_36.34.2288.79","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.4.621"},{"key":"2015090700384559000_36.34.2288.80","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8227(95)01064-K"},{"key":"2015090700384559000_36.34.2288.81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041031"},{"key":"2015090700384559000_36.34.2288.82","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"2015090700384559000_36.34.2288.83","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052187"},{"key":"2015090700384559000_36.34.2288.84","doi-asserted-by":"publisher","DOI":"10.1097\/HJR.0b013e3282f335d0"},{"key":"2015090700384559000_36.34.2288.85","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706245"},{"key":"2015090700384559000_36.34.2288.86","doi-asserted-by":"crossref","unstructured":"Inzucchi SE Bergenstal RM Buse JB Diamant M Ferrannini E Nauck M Peters AL Tsapas A Wender R Matthews DR . Management of hyperglycemia in type 2 diabetes, 2015: a patient-cent2red approach. Update to a position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2015;38:140\u2013149.","DOI":"10.2337\/dc14-2441"},{"key":"2015090700384559000_36.34.2288.87","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199508313330902"},{"key":"2015090700384559000_36.34.2288.88","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)07037-8"},{"key":"2015090700384559000_36.34.2288.89","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr077"},{"key":"2015090700384559000_36.34.2288.90","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0176-9"},{"key":"2015090700384559000_36.34.2288.91","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.12.2244"},{"key":"2015090700384559000_36.34.2288.92","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.19.2070"},{"key":"2015090700384559000_36.34.2288.93","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-157-9-201211060-00003"},{"key":"2015090700384559000_36.34.2288.94","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-9-54"},{"key":"2015090700384559000_36.34.2288.95","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2444"},{"key":"2015090700384559000_36.34.2288.96","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12116"},{"key":"2015090700384559000_36.34.2288.97","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0719"},{"key":"2015090700384559000_36.34.2288.98","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2004.02.028"},{"key":"2015090700384559000_36.34.2288.99","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.409"},{"key":"2015090700384559000_36.34.2288.100","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-012-6413-1"},{"key":"2015090700384559000_36.34.2288.101","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-004-1547-8"},{"key":"2015090700384559000_36.34.2288.102","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1681.2008.04920.x"},{"key":"2015090700384559000_36.34.2288.103","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2003.11.007"},{"key":"2015090700384559000_36.34.2288.104","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70152-9"},{"key":"2015090700384559000_36.34.2288.105","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-2116"},{"key":"2015090700384559000_36.34.2288.106","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7134.823"},{"key":"2015090700384559000_36.34.2288.107","doi-asserted-by":"publisher","DOI":"10.1042\/BST20130275"},{"key":"2015090700384559000_36.34.2288.108","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(90)90148-C"},{"key":"2015090700384559000_36.34.2288.109","unstructured":"Shepherd M Kushwaha R . Effect of metformin on basal and postprandial lipid and carbohydrate metabolism in NIDDM subjects. Diabetes 1994;43 (Suppl. 1):76A."},{"key":"2015090700384559000_36.34.2288.110","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.13.1.1"},{"key":"2015090700384559000_36.34.2288.111","doi-asserted-by":"publisher","DOI":"10.1210\/jc.74.5.1020"},{"key":"2015090700384559000_36.34.2288.112","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1014703"},{"key":"2015090700384559000_36.34.2288.113","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2003.07.020"},{"key":"2015090700384559000_36.34.2288.114","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.20.10.1598"},{"key":"2015090700384559000_36.34.2288.115","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9150(77)90142-3"},{"key":"2015090700384559000_36.34.2288.116","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.4.888"},{"key":"2015090700384559000_36.34.2288.117","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.4.621"},{"key":"2015090700384559000_36.34.2288.118","doi-asserted-by":"crossref","unstructured":"Reis JP1 Allen N Gunderson EP Lee JM Lewis CE Loria CM Powell-Wiley TM Rana JS Sidney S Wei G Yano Y Liu K . Excess body mass index- and waist circumference-years and incident cardiovascular disease: The CARDIA study. Obesity (Silver Spring). 2015 Mar 9. doi:10.1002\/oby.21023 doi:10.1002\/oby.21023. [Epub ahead of print]","DOI":"10.1002\/oby.21023"},{"key":"2015090700384559000_36.34.2288.119","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa075392"},{"key":"2015090700384559000_36.34.2288.120","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0141-7"},{"key":"2015090700384559000_36.34.2288.121","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcibr1409796"},{"key":"2015090700384559000_36.34.2288.122","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2004-0699"},{"key":"2015090700384559000_36.34.2288.123","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.suppl_2.S108"},{"key":"2015090700384559000_36.34.2288.124","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2006.12.021"},{"key":"2015090700384559000_36.34.2288.125","doi-asserted-by":"crossref","unstructured":"Del Prato S Pulizzi N . The place of sulfonylureas in the therapy for type 2 diabetes mellitus. Metabolism 2006;55 (Suppl. 1):S2\u2013S27.","DOI":"10.1016\/j.metabol.2006.02.003"},{"key":"2015090700384559000_36.34.2288.126","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-2082"},{"key":"2015090700384559000_36.34.2288.127","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199910073411501"},{"key":"2015090700384559000_36.34.2288.128","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003795"},{"key":"2015090700384559000_36.34.2288.129","unstructured":"Meinert CL Knatterud GL Prout TE Klimt CR . A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19(suppl):789\u2013830."},{"key":"2015090700384559000_36.34.2288.130","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12302"},{"key":"2015090700384559000_36.34.2288.131","doi-asserted-by":"publisher","DOI":"10.1097\/00045391-200603000-00009"},{"key":"2015090700384559000_36.34.2288.132","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.050748"},{"key":"2015090700384559000_36.34.2288.133","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0017"},{"key":"2015090700384559000_36.34.2288.134","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.736"},{"key":"2015090700384559000_36.34.2288.135","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.09.008"},{"key":"2015090700384559000_36.34.2288.136","doi-asserted-by":"crossref","unstructured":"Simpson SH Lee J Choi S Vandermeer B Abdelmoneim AS Featherstone TR . Mortality risk among sulfonylureas: a systematic review and network meta-analysis. Lancet 2015;3:43\u201351.","DOI":"10.1016\/S2213-8587(14)70213-X"},{"key":"2015090700384559000_36.34.2288.137","doi-asserted-by":"crossref","unstructured":"Patel A MacMahon S Chalmers J Neal B Billot L Woodward M Marre M Cooper M Glasziou P Grobbee D Hamet P Harrap S Heller S Liu L Mancia G Mogensen CE Pan C Poulter N Rodgers A Williams B Bompoint S de Galan BE Joshi R Travert F . Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560\u20132572.","DOI":"10.1056\/NEJMoa0802987"},{"key":"2015090700384559000_36.34.2288.138","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"2015090700384559000_36.34.2288.139","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-008-6138-3"},{"key":"2015090700384559000_36.34.2288.140","doi-asserted-by":"publisher","DOI":"10.1177\/1479164112475102"},{"key":"2015090700384559000_36.34.2288.141","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01230.x"},{"key":"2015090700384559000_36.34.2288.142","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-0167"},{"key":"2015090700384559000_36.34.2288.143","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020904"},{"key":"2015090700384559000_36.34.2288.144","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-011-0216-6"},{"key":"2015090700384559000_36.34.2288.145","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.235"},{"key":"2015090700384559000_36.34.2288.146","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06715-0"},{"key":"2015090700384559000_36.34.2288.147","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200422060-00005"},{"key":"2015090700384559000_36.34.2288.148","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2001.00490.x"},{"key":"2015090700384559000_36.34.2288.149","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(03)00057-3"},{"key":"2015090700384559000_36.34.2288.150","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(03)80090-5"},{"key":"2015090700384559000_36.34.2288.151","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.11.012"},{"key":"2015090700384559000_36.34.2288.152","doi-asserted-by":"publisher","DOI":"10.2337\/dcS13-2003"},{"key":"2015090700384559000_36.34.2288.153","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra041001"},{"key":"2015090700384559000_36.34.2288.154","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: updated risk evaluation and mitigation strategy (REMS) to restrict access to rosiglitazone-containing medicines including Avandia, Avandamet, and Avandaryl. May 18, 2011. http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm255005.htm . (24 February 2015)."},{"key":"2015090700384559000_36.34.2288.155","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01262.x"},{"key":"2015090700384559000_36.34.2288.156","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2013.05.004"},{"key":"2015090700384559000_36.34.2288.157","doi-asserted-by":"crossref","unstructured":"Young LH . Insulin resistance and the effects of thiazolidinediones on cardiac metabolism. Am J Med 2003;115 (Suppl. 8):75S\u201380S.","DOI":"10.1016\/j.amjmed.2003.09.013"},{"key":"2015090700384559000_36.34.2288.158","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100034"},{"key":"2015090700384559000_36.34.2288.159","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90960.2008"},{"key":"2015090700384559000_36.34.2288.160","doi-asserted-by":"publisher","DOI":"10.2337\/dc05-2445"},{"key":"2015090700384559000_36.34.2288.161","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.24.4.710"},{"key":"2015090700384559000_36.34.2288.162","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00551.2006"},{"key":"2015090700384559000_36.34.2288.163","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0265"},{"key":"2015090700384559000_36.34.2288.164","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.55.02.06.db05-1066"},{"key":"2015090700384559000_36.34.2288.165","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1515"},{"key":"2015090700384559000_36.34.2288.166","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.5.1021"},{"key":"2015090700384559000_36.34.2288.167","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.06.055"},{"key":"2015090700384559000_36.34.2288.168","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.746610"},{"key":"2015090700384559000_36.34.2288.169","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.7.1547"},{"key":"2015090700384559000_36.34.2288.170","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000090521.25968.4D"},{"key":"2015090700384559000_36.34.2288.171","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.3.343"},{"key":"2015090700384559000_36.34.2288.172","doi-asserted-by":"publisher","DOI":"10.1080\/08037050600853720"},{"key":"2015090700384559000_36.34.2288.173","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.30.387"},{"key":"2015090700384559000_36.34.2288.174","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.27.6.1349"},{"key":"2015090700384559000_36.34.2288.175","doi-asserted-by":"publisher","DOI":"10.1097\/01.fjc.0000187176.13403.05"},{"key":"2015090700384559000_36.34.2288.176","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-10-65"},{"key":"2015090700384559000_36.34.2288.177","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2009.02025.x"},{"key":"2015090700384559000_36.34.2288.178","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa060326"},{"key":"2015090700384559000_36.34.2288.179","doi-asserted-by":"publisher","DOI":"10.4158\/EP.9.5.406"},{"key":"2015090700384559000_36.34.2288.180","unstructured":"Clarke DC Molina-Wilkins M Martinez S Merovci A Kincade JR Solis-Herrera C Cerosimo E Chilton RJ Iozzo P Abdul-Ghani M DeFronzo RA . Improved left ventricular diastolic function (LVDF) following pioglitazone therapy is strongly related to increased myocardial insulin sensitivity. Diabetes 2014;63(Suppl 1):A298."},{"key":"2015090700384559000_36.34.2288.181","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"2015090700384559000_36.34.2288.182","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0717"},{"key":"2015090700384559000_36.34.2288.183","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.12.048"},{"key":"2015090700384559000_36.34.2288.184","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000257974.06317.49"},{"key":"2015090700384559000_36.34.2288.185","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2008.03.002"},{"key":"2015090700384559000_36.34.2288.186","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.10.1180"},{"key":"2015090700384559000_36.34.2288.187","doi-asserted-by":"publisher","DOI":"10.1001\/jama.299.13.1561"},{"key":"2015090700384559000_36.34.2288.188","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.21.joc60158"},{"key":"2015090700384559000_36.34.2288.189","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000165072.01672.21"},{"key":"2015090700384559000_36.34.2288.190","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007060678"},{"key":"2015090700384559000_36.34.2288.191","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b4731"},{"key":"2015090700384559000_36.34.2288.192","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3034"},{"key":"2015090700384559000_36.34.2288.193","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01306.x"},{"key":"2015090700384559000_36.34.2288.194","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2011.11.001"},{"key":"2015090700384559000_36.34.2288.195","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e1369"},{"key":"2015090700384559000_36.34.2288.196","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.158527"},{"key":"2015090700384559000_36.34.2288.197","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-011-0088-z"},{"key":"2015090700384559000_36.34.2288.198","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12000"},{"key":"2015090700384559000_36.34.2288.199","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01362.x"},{"key":"2015090700384559000_36.34.2288.200","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0340-2"},{"key":"2015090700384559000_36.34.2288.201","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2009.10.007"},{"key":"2015090700384559000_36.34.2288.202","doi-asserted-by":"publisher","DOI":"10.1253\/circj.CJ-12-1168"},{"key":"2015090700384559000_36.34.2288.203","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2421"},{"key":"2015090700384559000_36.34.2288.204","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2012.07.012"},{"key":"2015090700384559000_36.34.2288.205","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6823-10-7"},{"key":"2015090700384559000_36.34.2288.206","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-12-3"},{"key":"2015090700384559000_36.34.2288.207","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01215.x"},{"key":"2015090700384559000_36.34.2288.208","doi-asserted-by":"crossref","unstructured":"Frederich R Alexander JH Fiedorek FT Donovan M Berglind N Harris S Chen R Wolf R Mahaffey KW . A systematic assessment of cardiovascular outcomes in the saxagliptin drug development program for type 2 diabetes. Postgrad Med 2010;122:16\u201327.","DOI":"10.3810\/pgm.2010.05.2138"},{"key":"2015090700384559000_36.34.2288.209","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-6"},{"key":"2015090700384559000_36.34.2288.210","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12093"},{"key":"2015090700384559000_36.34.2288.211","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-11-3"},{"key":"2015090700384559000_36.34.2288.212","doi-asserted-by":"crossref","unstructured":"Richter B Bandeira-Echtler E Bergerhoff K Lerch CL . Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. The Cochrane Database of Syst Rev 2008:CD006739.","DOI":"10.1002\/14651858.CD006739.pub2"},{"key":"2015090700384559000_36.34.2288.213","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1307684"},{"key":"2015090700384559000_36.34.2288.214","doi-asserted-by":"publisher","DOI":"10.1210\/er.2011-1052"},{"key":"2015090700384559000_36.34.2288.215","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1305889"},{"key":"2015090700384559000_36.34.2288.216","unstructured":"Bethel M Green J Califf R Holman RR . Rationale and design of the trial evaluating cardiovascular outcomes with sitagliptin (TECOS). Diabetes 2009;58 (Suppl. 1):2152."},{"key":"2015090700384559000_36.34.2288.217","doi-asserted-by":"publisher","DOI":"10.1172\/JCI30076"},{"key":"2015090700384559000_36.34.2288.218","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2008.08.012"},{"key":"2015090700384559000_36.34.2288.219","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0291"},{"key":"2015090700384559000_36.34.2288.220","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.739938"},{"key":"2015090700384559000_36.34.2288.221","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.11.004"},{"key":"2015090700384559000_36.34.2288.222","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(03)00108-6"},{"key":"2015090700384559000_36.34.2288.223","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.108.766402"},{"key":"2015090700384559000_36.34.2288.224","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000139339.85840.DD"},{"key":"2015090700384559000_36.34.2288.225","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2440-x"},{"key":"2015090700384559000_36.34.2288.226","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2008.10.033"},{"key":"2015090700384559000_36.34.2288.227","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.54.1.146"},{"key":"2015090700384559000_36.34.2288.228","doi-asserted-by":"publisher","DOI":"10.2337\/db08-1193"},{"key":"2015090700384559000_36.34.2288.229","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2006.08.211"},{"key":"2015090700384559000_36.34.2288.230","doi-asserted-by":"publisher","DOI":"10.3132\/dvdr.2004.005"},{"key":"2015090700384559000_36.34.2288.231","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000120505.91348.58"},{"key":"2015090700384559000_36.34.2288.232","doi-asserted-by":"crossref","unstructured":"Halbirk M Norrelund H Moller N Holst JJ Schmitz O Nielsen R Nielsen-Kudsk JE Nielsen SS Nielsen TT Eiskjaer H B\u00f8tker HE Wiggers H . Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure. Am J Physiol Heart Cir Physiol 2010; 298:H1096\u2013H1102.","DOI":"10.1152\/ajpheart.00930.2009"},{"key":"2015090700384559000_36.34.2288.233","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2010.219345"},{"key":"2015090700384559000_36.34.2288.234","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.110.960476"},{"key":"2015090700384559000_36.34.2288.235","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr309"},{"key":"2015090700384559000_36.34.2288.236","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.5.1092"},{"key":"2015090700384559000_36.34.2288.237","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60659-0"},{"key":"2015090700384559000_36.34.2288.238","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01158.x"},{"key":"2015090700384559000_36.34.2288.239","doi-asserted-by":"crossref","unstructured":"Davies M Bode BW Kushner R Lewin AJ Skjoth TV Jensen CB DeFronzo R . Liraglutide 3.0 mg for Weight Management in Obese\/Overweight Adults with Type 2 Diabetes: Results from the SCALE\u2122 Diabetes 56- Week Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes 2014;63 (Suppl. 1):A26.","DOI":"10.1055\/s-0035-1556576"},{"key":"2015090700384559000_36.34.2288.240","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2009.245"},{"key":"2015090700384559000_36.34.2288.241","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)61206-4"},{"key":"2015090700384559000_36.34.2288.242","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.01.009"},{"key":"2015090700384559000_36.34.2288.243","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031403"},{"key":"2015090700384559000_36.34.2288.244","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1934"},{"key":"2015090700384559000_36.34.2288.245","doi-asserted-by":"crossref","unstructured":"Nystrom T Gutniak MK Zhang Q Zhang F Holst JJ Ahren B Sj\u00f6holm A . Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease. Am J Physiol Endocrinol Metab 2004;287:E1209-E1215.","DOI":"10.1152\/ajpendo.00237.2004"},{"key":"2015090700384559000_36.34.2288.246","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00373.2007"},{"key":"2015090700384559000_36.34.2288.247","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00376.x"},{"key":"2015090700384559000_36.34.2288.248","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2010.05.028"},{"key":"2015090700384559000_36.34.2288.249","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-0126-y"},{"key":"2015090700384559000_36.34.2288.250","doi-asserted-by":"publisher","DOI":"10.2337\/dc08-2124"},{"key":"2015090700384559000_36.34.2288.251","unstructured":"Plutzky J Garber AD . Meta-analysis demonstrates that liraglutide, a once-daily human GLP-1 analogue, significantly reduces lipids and other markers of cardiovascular risk in type 2 diabetes. Diabetologia 2009;52 (Suppl. 1):A762-P."},{"key":"2015090700384559000_36.34.2288.252","doi-asserted-by":"publisher","DOI":"10.1185\/030079907X253870"},{"key":"2015090700384559000_36.34.2288.253","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2006.00602.x"},{"key":"2015090700384559000_36.34.2288.254","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01357.x"},{"key":"2015090700384559000_36.34.2288.255","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-82617"},{"key":"2015090700384559000_36.34.2288.256","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1611-5"},{"key":"2015090700384559000_36.34.2288.257","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.144154"},{"key":"2015090700384559000_36.34.2288.258","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2009.0141"},{"key":"2015090700384559000_36.34.2288.259","unstructured":"Kendall DM Bhole D Guan X Nielsen L Trautmann M Wintle M Kim D . Exenatide treatment for 82 weeks reduced C-reactive protein, HbA1c, and body weight in patients with type 2 diabetes mellitus. Diabetologia 2006;49(suppl 1):475."},{"key":"2015090700384559000_36.34.2288.260","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02484.x"},{"key":"2015090700384559000_36.34.2288.261","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0387"},{"key":"2015090700384559000_36.34.2288.262","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-08-0468"},{"key":"2015090700384559000_36.34.2288.263","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2009.10.015"},{"key":"2015090700384559000_36.34.2288.264","doi-asserted-by":"publisher","DOI":"10.1177\/1479164111408937"},{"key":"2015090700384559000_36.34.2288.265","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1393"},{"key":"2015090700384559000_36.34.2288.266","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0387"},{"key":"2015090700384559000_36.34.2288.267","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0029"},{"key":"2015090700384559000_36.34.2288.268","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2011.243"},{"key":"2015090700384559000_36.34.2288.269","doi-asserted-by":"publisher","DOI":"10.1172\/JCI112981"},{"key":"2015090700384559000_36.34.2288.270","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72227"},{"key":"2015090700384559000_36.34.2288.271","doi-asserted-by":"publisher","DOI":"10.1172\/JCI70704"},{"key":"2015090700384559000_36.34.2288.272","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3472"},{"key":"2015090700384559000_36.34.2288.273","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-11-43"},{"key":"2015090700384559000_36.34.2288.274","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2012-001007"},{"key":"2015090700384559000_36.34.2288.275","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2013.774372"},{"key":"2015090700384559000_36.34.2288.276","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-014-0225-5"},{"key":"2015090700384559000_36.34.2288.277","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2013.05.2667"},{"key":"2015090700384559000_36.34.2288.278","unstructured":"Bischoff H . The mechanism of alpha-glucosidase inhibition in the management of diabetes. Clin Invest Med 1995;18:303\u2013311."},{"key":"2015090700384559000_36.34.2288.279","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-14-0555"},{"key":"2015090700384559000_36.34.2288.280","doi-asserted-by":"crossref","unstructured":"Su B Liu H Li J Sunli Y Liu B Liu D Zhang P Meng X . Acarbose treatment affects the serum levels of inflammatory cytokines and the gut content of bifidobacteria in Chinese patients with type 2 diabetes mellitus. J Diabetes 2014 Oct 18. doi:10.1111\/1753-0407.12232 doi:10.1111\/1753-0407.12232.","DOI":"10.1111\/1753-0407.12232"},{"key":"2015090700384559000_36.34.2288.281","doi-asserted-by":"crossref","unstructured":"Rabasa-Lhoret R Chiasson JL . Alpha-glucosidase inhibitors. In: DeFronozo RA Ferrannini E Keen H Zimmet P (eds), International Textbook of Diabetes Mellitus. 3rd ed. Chichester, West Sussex, UK: John Wiley & Sons, Inc., 2004.","DOI":"10.1002\/0470862092.d0612"},{"key":"2015090700384559000_36.34.2288.282","doi-asserted-by":"crossref","unstructured":"Leonhardt W Hanefeld M Fischer S Schulze J . Efficacy of alpha-glucosidase inhibitors on lipids in NIDDM subjects with moderate hyperlipidaemia. Eur J Clin Invest 1994;24 (Suppl. 3):45\u201349.","DOI":"10.1111\/j.1365-2362.1994.tb02256.x"},{"key":"2015090700384559000_36.34.2288.283","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8227(98)00062-X"},{"key":"2015090700384559000_36.34.2288.284","unstructured":"Mughal MA Memon MY Zardari MK Tanwani RK Ali M . Effect of acarbose on glycemic control, serum lipids and lipoproteins in type 2 diabetes. J Pak Med Assoc 2000;50:152\u2013155."},{"key":"2015090700384559000_36.34.2288.285","doi-asserted-by":"publisher","DOI":"10.1046\/j.1463-1326.2000.00065.x"},{"key":"2015090700384559000_36.34.2288.286","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.7.1154"},{"key":"2015090700384559000_36.34.2288.287","doi-asserted-by":"crossref","unstructured":"Halimi S Le Berre MA Grange V . Efficacy and safety of acarbose add-on therapy in the treatment of overweight patients with type 2 diabetes inadequately controlled with metformin: a double-blind, placebo-controlled study. Diabetes Res Clin Pract 2000;50:49\u201356.","DOI":"10.1016\/S0168-8227(00)00163-7"},{"key":"2015090700384559000_36.34.2288.288","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08905-5"},{"key":"2015090700384559000_36.34.2288.289","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.4.486"},{"key":"2015090700384559000_36.34.2288.290","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2014.03.021"},{"key":"2015090700384559000_36.34.2288.291","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905479"},{"key":"2015090700384559000_36.34.2288.292","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.16.1.21"},{"key":"2015090700384559000_36.34.2288.293","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12280"},{"key":"2015090700384559000_36.34.2288.294","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2009.01125.x"},{"key":"2015090700384559000_36.34.2288.295","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3042"},{"key":"2015090700384559000_36.34.2288.296","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61969-3"},{"key":"2015090700384559000_36.34.2288.297","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-1318"},{"key":"2015090700384559000_36.34.2288.298","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f2267"},{"key":"2015090700384559000_36.34.2288.299","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(99)90081-1"},{"key":"2015090700384559000_36.34.2288.300","doi-asserted-by":"publisher","DOI":"10.1016\/0026-0495(81)90167-0"},{"key":"2015090700384559000_36.34.2288.301","doi-asserted-by":"publisher","DOI":"10.1042\/bj3500389"},{"key":"2015090700384559000_36.34.2288.302","doi-asserted-by":"publisher","DOI":"10.1007\/BF01219472"},{"key":"2015090700384559000_36.34.2288.303","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111764"},{"key":"2015090700384559000_36.34.2288.304","doi-asserted-by":"crossref","unstructured":"Coletta DK Balas B Chavez AO Baig M Abdul-Ghani M Kashyap SR Folli F Tripathy D Mandarino LJ Cornell JE Defronzo RA Jenkinson CP . Effect of acute physiological hyperinsulinemia on gene expression in human skeletal muscle in vivo. Am J Physiol Endocrinol Metab 2008; 294:E910\u2013E917.","DOI":"10.1152\/ajpendo.00607.2007"},{"key":"2015090700384559000_36.34.2288.305","doi-asserted-by":"publisher","DOI":"10.2337\/diab.34.2.185"},{"key":"2015090700384559000_36.34.2288.306","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262020"},{"key":"2015090700384559000_36.34.2288.307","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.9.1.39"},{"key":"2015090700384559000_36.34.2288.308","doi-asserted-by":"publisher","DOI":"10.1084\/jem.89.6.611"},{"key":"2015090700384559000_36.34.2288.309","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.8.3.572"},{"key":"2015090700384559000_36.34.2288.310","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.23.6.1012"},{"key":"2015090700384559000_36.34.2288.311","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400466"},{"key":"2015090700384559000_36.34.2288.312","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00004.2012"},{"key":"2015090700384559000_36.34.2288.313","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67166"},{"key":"2015090700384559000_36.34.2288.314","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.96.3.849"},{"key":"2015090700384559000_36.34.2288.315","doi-asserted-by":"publisher","DOI":"10.2337\/diab.37.6.780"},{"key":"2015090700384559000_36.34.2288.316","doi-asserted-by":"publisher","DOI":"10.1016\/S0026-0495(96)90122-5"},{"key":"2015090700384559000_36.34.2288.317","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.16107"},{"key":"2015090700384559000_36.34.2288.318","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808431"},{"key":"2015090700384559000_36.34.2288.319","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60611-5"},{"key":"2015090700384559000_36.34.2288.320","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.17.7.1337"},{"key":"2015090700384559000_36.34.2288.321","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1470-0"},{"key":"2015090700384559000_36.34.2288.322","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/eht332"},{"key":"2015090700384559000_36.34.2288.323","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2011.01468.x"},{"key":"2015090700384559000_36.34.2288.324","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32832e9500"},{"key":"2015090700384559000_36.34.2288.325","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-13-26"},{"key":"2015090700384559000_36.34.2288.326","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0b013e32834d68f0"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/eurheartj\/article-pdf\/36\/34\/2288\/7110376\/ehv239.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T13:41:12Z","timestamp":1566826872000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-lookup\/doi\/10.1093\/eurheartj\/ehv239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,10]]},"references-count":326,"journal-issue":{"issue":"34","published-online":{"date-parts":[[2015,9,7]]},"published-print":{"date-parts":[[2015,9,7]]}},"alternative-id":["10.1093\/eurheartj\/ehv239"],"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehv239","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,10]]}}}